Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.
BRL 26921 is a protected plasminogen-streptokinase complex with selective affinity for thrombus. When given intravenously within three hours of the onset of a first acute myocardial infarction angiographic patency of the infarct related vessel was seen in all 16 patients receiving the active drug co...
Guardado en:
| Publicado en: | Br Heart J |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
1985
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481752/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3882107/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.3.253 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
